Renal Cortical Necrosis 

  • Author: Prasad Devarajan, MD; Chief Editor: Craig B Langman, MD   more...
 
Updated: May 26, 2011
 

Background

Renal cortical necrosis is a rare cause of acute renal failure secondary to ischemic necrosis of the renal cortex. The lesions are usually caused by significantly diminished renal arterial perfusion secondary to vascular spasm, microvascular injury, or intravascular coagulation. Renal cortical necrosis is usually extensive, although focal and localized forms occur. In most cases, the medulla, juxtamedullary cortex, and a thin rim of subcapsular cortex are spared. (See Etiology.)

Classification

Renal cortical necrosis is classified into 5 pathologic forms, depending on severity, as follows:

  • Focal pathologic form - Kidneys show focally necrotic glomeruli without thrombosis and patchy necrosis of tubules
  • Minor pathologic form - Larger foci of necrosis are evident with vascular and glomerular thrombi
  • Patchy pathologic form - Patches of necrosis may occupy two thirds of the cortex
  • Gross pathologic form - Almost the entire cortex is involved; thrombosis of the arteries is more widespread
  • Confluent pathologic form - Kidneys show widespread glomerular and tubular necrosis with no arterial involvement

Complications

Acute renal failure is typical in patients with renal cortical necrosis, with associated complications (eg, hyperkalemia, fluid overload).

Chronic renal failure, occurring in 30-50% of patients, requires dialysis and transplantation. (See Treatment.)

Go to Acute Renal Failure and Acute Tubular Necrosis for complete information on these topics.

Next

Etiology

Cases of renal cortical necrosis are usually bilateral. Although the pathogenesis of the disease remains unclear, the presumed initiating factor is intense vasospasm of the small vessels. If this vasospasm is brief and vascular flow is reestablished, acute tubular necrosis results. More prolonged vasospasm can cause necrosis and thrombosis of the distal arterioles and glomeruli, and renal cortical necrosis ensues.

In hemolytic-uremic syndrome (HUS) and septic abortion, an additional mechanism involves endotoxin-mediated endothelial damage that leads to vascular thrombosis.

Studies have shown that patients with HUS with thrombotic microangiopathy (TMA) involving arteries have a higher likelihood of progressing into acute cortical necrosis compared with patients with predominant glomerular TMA.[1]

Renal cortical necrosis in placental abruption may be due to a combination of a hypercoagulable state, endothelial injury, and intravascular thrombosis.

Neonatal risk factors

Neonatal conditions that may lead to renal cortical necrosis include the following:

  • Congenital heart disease
  • Fetal-maternal transfusion
  • Dehydration
  • Perinatal asphyxia
  • Anemia
  • Placental hemorrhage
  • Severe hemolytic disease
  • Sepsis

Childhood risk factors

Childhood conditions that may lead to renal cortical necrosis include the following:

  • HUS
  • Acute gastroenteritis with dehydration

Pregnancy-related risk factors

Pregnancy-related conditions (more than 50% of cases) that may lead to renal cortical necrosis include the following:

  • Placental abruption
  • Infected abortion
  • Prolonged intrauterine fetal death
  • Severe eclampsia

Additional risk factors

Miscellaneous conditions that may lead to renal cortical necrosis include the following:

  • Sepsis
  • Shock
  • Trauma
  • Snakebite
  • Hyperacute kidney transplant rejection
  • Poisons
  • Drugs (eg, nonsteroidal anti-inflammatory drugs [NSAIDs])
  • Contrast media
Previous
Next

Epidemiology

Incidence in the United States

Renal cortical necrosis accounts for 2% of all cases of acute renal failure in adults and more than 20% of acute renal failure during the third trimester of pregnancy. Renal cortical necrosis was detected by postmortem examination in 5% of infants aged 3 months or younger at death.

International incidence

Renal cortical necrosis incidence is higher in developing countries, ranging from 6-7% of all cases of acute renal failure. The incidence of acute cortical necrosis has been decreasing in developing countries over the past years.

The incidence of renal cortical necrosis was reported to be 3.12% of all cases of acute renal failure based on a study from India.[2] Acute cortical necrosis due to obstetric causes was observed in 56.2% of patients, whereas nonobstetric causes accounted for acute renal failure in 43.8% of the patients.

Race predilection

Renal cortical necrosis has no race predilection.

Sex predilection

In childhood, renal cortical necrosis equally affects both sexes. In adults, renal cortical necrosis occurs more frequently in women, because the most common cause is placental abruption (50% of all cases).

Age predilection

The first peak of renal cortical necrosis occurrence is in early infancy and is associated with severe perinatal events or conditions. Renal cortical necrosis in childhood is usually secondary to HUS or severe volume depletion. Occurrence also peaks in women of childbearing age because of obstetric causes.[3]

Previous
Next

Prognosis

In untreated patients, the mortality rate from renal cortical necrosis exceeds 50%. Early initiation of dialysis significantly diminishes this rate.

The most important prognostic factors are the extent of necrosis, duration of oliguria, and severity of associated conditions.

Infant survival rates are low because of associated conditions.

Severe congenital heart disease is a major risk factor for death.

Of those patients who survive, most require dialysis for variable periods of time, depending on the extent of necrosis. Some patients have recovered renal function even after several months of oliguria.

Previous
Next

Patient Education

For patient education information, see the Diabetes Center and the Kidneys and Urinary System Center, as well as Acute Kidney Failure and Blood in the Urine.

Previous
 
 
Contributor Information and Disclosures
Author

Prasad Devarajan, MD  Louise M Williams Endowed Chair in Pediatrics, Professor of Pediatrics and Developmental Biology, Director of Nephrology and Hypertension, Director of Clinical Nephrology Laboratories, Chief Executive Officer of Dialysis Unit, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine

Prasad Devarajan, MD is a member of the following medical societies: American Heart Association, American Society of Nephrology, American Society of Pediatric Nephrology, National Kidney Foundation, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Specialty Editor Board

Laurence Finberg, MD  Clinical Professor, Department of Pediatrics, University of California, San Francisco, School of Medicine and Stanford University School of Medicine

Laurence Finberg, MD is a member of the following medical societies: American Medical Association

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Luther Travis, MD  Professor Emeritus, Departments of Pediatrics, Nephrology and Diabetes, University of Texas Medical Branch School of Medicine

Luther Travis, MD is a member of the following medical societies: Alpha Omega Alpha, American Federation for Medical Research, International Society of Nephrology, and Texas Pediatric Society

Disclosure: Nothing to disclose.

Chief Editor

Craig B Langman, MD  The Isaac A Abt, MD, Professor of Kidney Diseases, Northwestern University, The Feinberg School of Medicine; Division Head of Kidney Diseases, Children's Memorial Hospital

Craig B Langman, MD is a member of the following medical societies: American Academy of Pediatrics, American Society of Nephrology, and International Society of Nephrology

Disclosure: Merck Grant/research funds None; NIH Grant/research funds None; Raptor Pharmaceuticals, Inc Grant/research funds None; Alexion Pharmaceuticals, Inc. Grant/research funds None

References
  1. Kamioka I, Nozu K, Fujita T, Kaito H, Tanaka R, Yoshiya K, et al. Prognosis and pathological characteristics of five children with non-Shiga toxin-mediated hemolytic uremic syndrome. Pediatr Int. Apr 2007;49(2):196-201. [Medline].

  2. Prakash J, Vohra R, Wani IA, Murthy AS, Srivastva PK, Tripathi K, et al. Decreasing incidence of renal cortical necrosis in patients with acute renal failure in developing countries: a single-centre experience of 22 years from Eastern India. Nephrol Dial Transplant. Apr 2007;22(4):1213-7. [Medline].

  3. Ali A, Ali MA, Ali MU, Mohammad S. Hospital outcomes of obstetrical-related acute renal failure in a tertiary care teaching hospital. Ren Fail. 2011;33(3):285-90. [Medline].

  4. Papnicolaou N, Francis IR, Casalino DD, Arellano RS, Baumgarten DA, Curry NS, et al. ACR Appropriateness Criteria renal failure. [online publication]. Reston, VA: American College of Radiology (ACR); 2008.

  5. Archer L, Kilburn-Toppin F, Sneddon K, et al. A "fussy eater" with renal failure. Lancet. Feb 20 2010;375(9715):696. [Medline].

  6. Krishna GS, Kishore KC, Sriram NP, et al. Bilateral renal cortical necrosis in acute pancreatitis. Indian J Nephrol. Jul 2009;19(3):125. [Medline]. [Full Text].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.